M&T Bank Corp Ligand Pharmaceuticals Inc Transaction History

M&T Bank Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$74.52 - $117.06 $262,533 - $412,402	-3,523 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$94.99 - $151.56 $569 - $909	-6 Reduced 0.17%	3,523 $397,000
Q4 2021 Feb 07, 2022	BUY	$127.69 - $165.85 $73,677 - $95,695	577 Added 19.55%	3,529 $545,000
Q3 2021 Oct 28, 2021	BUY	$102.33 - $144.73 $20,670 - $29,235	202 Added 7.35%	2,952 $412,000
Q2 2021 Aug 13, 2021	BUY	$113.03 - $155.64 $111,899 - $154,083	990 Added 56.25%	2,750 $361,000
Q1 2021 May 06, 2021	SELL	$99.52 - $215.83 $254,273 - $551,445	-2,555 Reduced 59.21%	1,760 $268,000
Q3 2020 Nov 06, 2020	BUY	$89.56 - $126.72 $40,481 - $57,277	452 Added 11.7%	4,315 $411,000
Q2 2020 Jul 29, 2020	SELL	$68.28 - $123.65 $2,662 - $4,822	-39 Reduced 1.0%	3,863 $433,000
Q1 2020 May 14, 2020	BUY	$63.37 - $107.88 $247,269 - $420,947	3,902 New	3,902 $284,000
Q4 2018 Feb 01, 2019	SELL	$128.36 - $272.13 $127,846 - $271,041	-996 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$211.18 - $274.49 $55,329 - $71,916	-262 Reduced 20.83%	996 $274,000
Q2 2018 Aug 10, 2018	SELL	$150.77 - $207.98 $49,754 - $68,633	-330 Reduced 20.78%	1,258 $261,000
Q1 2018 May 04, 2018	SELL	$138.63 - $182.62 $49,768 - $65,560	-359 Reduced 18.44%	1,588 $262,000
Q4 2017 Feb 06, 2018	BUY	$128.36 - $147.04 $46,594 - $53,375	363 Added 22.92%	1,947 $267,000
Q3 2017 Nov 13, 2017	BUY	$120.91 - $137.94 $191,521 - $218,496	1,584	1,584 $216,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.